美国临床肿瘤学会-美国病理学家学会关于乳腺癌雌激素受体/孕激素受体及人表皮生长因子受体2检测指南建议的临床声明 - Suppr

Suppr

超能文献

Clinical Notice for American Society of Clinical Oncology-College of American Pathologists guideline recommendations on ER/PgR and HER2 testing in breast cancer.

作者信息

Hammond M Elizabeth, Hayes Daniel F, Wolff Antonio C

出版信息

J Clin Oncol. 2011 May 20;29(15):e458. doi: 10.1200/JCO.2011.35.2245. Epub 2011 Apr 18.

DOI:10.1200/JCO.2011.35.2245

PMID:21502545

Abstract

摘要

相似文献

Clinical Notice for American Society of Clinical Oncology-College of American Pathologists guideline recommendations on ER/PgR and HER2 testing in breast cancer.

J Clin Oncol. 2011 May 20;29(15):e458. doi: 10.1200/JCO.2011.35.2245. Epub 2011 Apr 18.

Quantitative justification of the change from 10% to 30% for human epidermal growth factor receptor 2 scoring in the American Society of Clinical Oncology/College of American Pathologists guidelines: tumor heterogeneity in breast cancer and its implications for tissue microarray based assessment of outcome.

J Clin Oncol. 2007 Dec 1;25(34):5418-25. doi: 10.1200/JCO.2007.12.8033.

Breast Cancer Biomarkers: Challenges in Routine Estrogen Receptor, Progesterone Receptor, and HER2/neu Evaluation.

Arch Pathol Lab Med. 2019 Dec;143(12):1444-1449. doi: 10.5858/arpa.2019-0205-RA. Epub 2019 Aug 2.

[Estrogen receptor (ER), progesterone receptor (PR)].

Nihon Rinsho. 2005 Aug;63 Suppl 8:762-4.

Estrogen receptor, progesterone receptor, HER-2, and response to postmastectomy radiotherapy in high-risk breast cancer: the Danish Breast Cancer Cooperative Group.

J Clin Oncol. 2008 Mar 20;26(9):1419-26. doi: 10.1200/JCO.2007.14.5565. Epub 2008 Feb 19.

The reliability of rabbit monoclonal antibodies in the immunohistochemical assessment of estrogen receptors, progesterone receptors, and HER2 in human breast carcinomas.

Am J Clin Pathol. 2010 Oct;134(4):621-32. doi: 10.1309/AJCPOG3O3KTPZQNK.

[Prognostic and predictive factors in breast cancer].

Vopr Onkol. 2005;51(4):434-43.

Oestrogen receptor/progesterone receptor and human epidermal growth factor receptor 2 status in breast cancer: a 9-year study at Princess Noorah Oncology Center, Saudi Arabia.

Histopathology. 2011 Sep;59(3):537-42. doi: 10.1111/j.1365-2559.2011.03883.x. Epub 2011 Jun 13.

Immunohistochemical detection of estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 expression in breast carcinomas: comparison on cell block, needle-core, and tissue block preparations.

Cancer. 2009 Aug 25;117(4):279-88. doi: 10.1002/cncy.20034.

The association of infrared imaging findings of the breast with hormone receptor and human epidermal growth factor receptor 2 status of breast cancer.

Acad Radiol. 2011 Feb;18(2):212-9. doi: 10.1016/j.acra.2010.09.016. Epub 2010 Dec 3.

引用本文的文献

MRI-based texture analysis for breast cancer subtype classification in a multi-ethnic population.

MAGMA. 2025 Aug 12. doi: 10.1007/s10334-025-01285-9.

Prediction of pathological complete response after neoadjuvant chemotherapy for HER2-negative breast cancer patients with routine immunohistochemical markers.

Breast Cancer Res. 2025 Jan 24;27(1):13. doi: 10.1186/s13058-025-01960-8.

Investigation of breast cancer molecular subtype in a multi-ethnic population using MRI.

PLoS One. 2024 Aug 29;19(8):e0309131. doi: 10.1371/journal.pone.0309131. eCollection 2024.

Narrative review of progress in pathological diagnosis of breast cancer.

Transl Breast Cancer Res. 2022 Apr 30;3:16. doi: 10.21037/tbcr-22-11. eCollection 2022.

and () Downregulation by Neoadjuvant Therapy is Associated with Better Therapeutic Outcomes and Survival in Breast Cancer.

J Oncol. 2022 Nov 28;2022:6001947. doi: 10.1155/2022/6001947. eCollection 2022.

Mir-4728 is a Valuable Biomarker for Diagnostic and Prognostic Assessment of HER2-Positive Breast Cancer.

Front Mol Biosci. 2022 May 17;9:818493. doi: 10.3389/fmolb.2022.818493. eCollection 2022.

Feasibility of Shear Wave Elastography Imaging for Evaluating the Biological Behavior of Breast Cancer.

Front Oncol. 2022 Jan 27;11:820102. doi: 10.3389/fonc.2021.820102. eCollection 2021.

Variable Expression of the Disialoganglioside GD2 in Breast Cancer Molecular Subtypes.

Cancers (Basel). 2021 Nov 8;13(21):5577. doi: 10.3390/cancers13215577.

Ki67 and progesterone receptor status predicts sensitivity to palbociclib: a real-world study.

Ann Transl Med. 2021 Apr;9(8):707. doi: 10.21037/atm-21-1340.

PIWI-Like 1 and PIWI-Like 2 Expression in Breast Cancer.

Cancers (Basel). 2020 Sep 24;12(10):2742. doi: 10.3390/cancers12102742.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验